Effect of Akkermansia Muciniphila WST01 Strain in Overweight or Obese Patients With Type 2 Diabetes
Status:
Recruiting
Trial end date:
2022-10-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to conduct a randomized, double-blinded, placebo-controlled,
multicenter clinical trial, evaluating the glucose-lowering and weight-loss effects of
Akkermansia muciniphila WST01 strain in overweight or obese patients with Type 2 Diabetes.